Partnering Webinars
-
CRO Selection Science: Insights From $2B+ Vendor Choices
12/15/2025
Discover how data-driven strategies and structured RFPs can simplify CRO selection, improve transparency, and ensure the right operational fit. Learn practical steps to make smarter vendor decisions.
-
Start Your Journey With Block Clinical
12/10/2025
Achieve unprecedented transparency with a platform designed to help you plan, manage, and analyze patient and site support costs instantly and effortlessly.
-
Should Sponsors Provide Source Document Templates?
12/9/2025
Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.
-
Trials Without Borders: Episode 5
12/4/2025
In Episode 5 of Trials Without Borders, we explore Canada's clinical trial ecosystem with expert panelists Erin Cherban (Chief Clinical Research Officer, Centre Advancing Health Outcomes/CIHR Pan-Canadian Network), Melissa Bomben (CEO, True North Innovation Agency and fractional COO of Biorasi), and Sergey Nikitin (Founder and President, Prime Site Research Solutions Inc.).
-
Australia's Edge In Oncology And Nuclear Medicine Trials
11/21/2025
Discover how we leverage Australia’s world-class clinical infrastructure, streamlined regulatory environment, and early-phase expertise to accelerate oncology and nuclear medicine trials.
-
CRO Solutions Expo: Clinical Research Is A Delicate Ecosystem
11/21/2025
Elevate your complex oncology program by partnering with a team that delivers transparent communication, deep expertise, and the focused attention emerging and midsized biotechs need to succeed.
-
Finding The Right CRO Partner For Early-Stage Oncology Trials
11/21/2025
Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.
-
Successful Implementation Of A Drug-Device Combination Submission
11/21/2025
Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.
-
How Small Biotechs Can Afford An FSP Model
11/7/2025
Lois Kelly explains how smaller biopharma companies can make an FSP model work even with limited budgets. She details how she built her own RFPs, compared boutique and large CROs, and emphasized governance, alignment, and relationships over cost alone.
-
Why Big Pharma Is Shifting Toward FSP Solutions
11/7/2025
Samir Shah describes how large pharmaceutical companies are moving decisively toward FSP-derived models. He explains how AI investments, cost efficiency, and improved control over operations are driving a lasting structural shift — not a short-term trend — across the industry.